Inclusion of sex chromosomes in noninvasive prenatal testing in Asia, Australia, Europe and the USA: A survey study
Prenatal Diagnosis · 2023-02 · 43 (2) · 144-155
DOI: 10.1002/pd.6322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, online erschienen am 07.02.2023. Verfasst von Ellen Hollands Steffensen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Fetal Diagnostics, Aarhus University, Aarhus, Denmark. Hauptthemen laut MEDLINE: Noninvasive Prenatal Testing. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: HCRW_, Novo Nordisk Fonden, Aarhus University, Faculty of Health.
Abstract (Originalsprache)
Objective
To examine the extent to which sex chromosomes are included in current noninvasive prenatal testing (NIPT) and the reporting practices with respect to fetal chromosomal sex and sex chromosome aberrations (SCAs), in addition to an update on the general implementation of NIPT.
Method
A questionnaire addressing the research objectives was distributed by email to fetal medicine and clinical genetics experts in Asia, Australia, Europe and the USA.
Results
Guidelines on NIPT are available in the majority of the included countries. Not all existing guidelines address reporting of fetal chromosomal sex and SCAs. In most settings, NIPT frequently includes sex chromosomes (five Australian states, China, Hong Kong, Israel, Singapore, Thailand, USA and 23 of 31 European countries). This occurs most often by default or when parents wish to know fetal sex. In most settings, a potential SCA is reported by stating the risk hereof as “low” or “high” and/or by naming the SCA. Less than 50% of all pregnant women receive NIPT according to respondents from three Australian states, China, Israel, Singapore, Thailand and 24 of 31 European countries. However, this percentage, the genomic coverage of NIPT and its application as primary or secondary screening vary by setting.
Conclusion
In most of the studied countries/states, NIPT commonly includes sex chromosomes. The reporting practices concerning fetal chromosomal sex and SCAs are diverse and most commonly not addressed by guidelines. In general, NIPT is variably implemented across countries/states.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Fetal Diagnostics, Aarhus University, Aarhus, Denmark.
- Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
- Department of Obstetrics, Center for Fetal Medicine, Pregnancy and Ultrasound, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Ellen Hollands Steffensen
Förderung
- HCRW_
- Novo Nordisk Fonden
- Aarhus University, Faculty of Health
- Health Research Fund of Central Denmark Region
- Danmarks Frie Forskningsfond
- Helsefonden
- Health and Care Research Wales
Zitieren
APA
Steffensen, E. H., Skakkebaek, A., Gadsbøll, K., Petersen, O. B., Westover, T., Strange, H., NIPT-SCA-map Study Group, & Vogel, I. (2023). Inclusion of sex chromosomes in noninvasive prenatal testing in Asia, Australia, Europe and the USA: A survey study. Prenatal Diagnosis, 43(2), 144-155. https://doi.org/10.1002/pd.6322
Vancouver
Steffensen EH, Skakkebaek A, Gadsbøll K, Petersen OB, Westover T, Strange H, et al. Inclusion of sex chromosomes in noninvasive prenatal testing in Asia, Australia, Europe and the USA: A survey study. Prenatal Diagnosis. 2023;43(2):144-155. doi:10.1002/pd.6322
BibTeX
@article{Steffensen2023,
author = {Steffensen, Ellen Hollands and Skakkebaek, Anne and Gadsbøll, Kasper and Petersen, Olav Bjørn and Westover, Thomas and Strange, Heather and NIPT-SCA-map Study Group, NIPT-SCA-map Study Group and Vogel, Ida},
title = {Inclusion of sex chromosomes in noninvasive prenatal testing in Asia, Australia, Europe and the USA: A survey study},
journal = {Prenatal Diagnosis},
year = {2023},
volume = {43},
number = {2},
pages = {144--155},
doi = {10.1002/pd.6322}
}
EUVIMED